Literature DB >> 17217913

A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF.

Norbert W Lutz1, Angèle Viola, Irina Malikova, Sylviane Confort-Gouny, Jean-Philippe Ranjeva, Jean Pelletier, Patrick J Cozzone.   

Abstract

(1)H NMR spectroscopy of cerebrospinal fluid (CSF) is currently being used to study metabolic profiles characteristic of distinct multiple sclerosis (MS) manifestations. For select MS patient groups, we have previously detected significantly increased concentrations of several identified metabolites and one unidentified compound. We now present, for the first time, the identification of the latter molecule, beta-hydroxyisobutyrate (BHIB). A combination of dedicated 1D and 2D (1)H NMR experiments was employed for signal assignment. To our knowledge, BHIB has not previously been identified in (1)H NMR spectra of biofluids or biological tissues. Our assignment suggests new biochemical pathways involved in specific MS pathologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217913     DOI: 10.1016/j.bbrc.2006.12.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.

Authors:  J Singh; M Cerghet; L M Poisson; I Datta; K Labuzek; H Suhail; R Rattan; Shailendra Giri
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-12       Impact factor: 4.147

Review 2.  Methodological Developments for Metabolic NMR Spectroscopy from Cultured Cells to Tissue Extracts: Achievements, Progress and Pitfalls.

Authors:  Norbert W Lutz; Monique Bernard
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

Review 3.  Metabolomics--a novel window into inflammatory disease.

Authors:  Martin Fitzpatrick; Stephen P Young
Journal:  Swiss Med Wkly       Date:  2013-01-21       Impact factor: 2.193

4.  Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

Authors:  Jan O Aasly; Oddbjørn Sæther; Krisztina K Johansen; Tone F Bathen; Guro F Giskeødegård; Linda R White
Journal:  Parkinsons Dis       Date:  2015-08-18

5.  1H NMR Analysis of Cerebrospinal Fluid from Alzheimer's Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH.

Authors:  Thomas Cruz; Stéphane Balayssac; Véronique Gilard; Robert Martino; Christian Vincent; Jérémie Pariente; Myriam Malet-Martino
Journal:  Metabolites       Date:  2014-02-19

Review 6.  An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.

Authors:  Insha Zahoor; Bin Rui; Junaid Khan; Indrani Datta; Shailendra Giri
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

7.  Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.

Authors:  Norbert W Lutz; Angèle Viola; Irina Malikova; Sylviane Confort-Gouny; Bertrand Audoin; Jean-Philippe Ranjeva; Jean Pelletier; Patrick J Cozzone
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.